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Abstract: This study aimed at investigating the effect of coffee 
formulation and high-pressure homogenization (HPH) on chlorogenic acid 
bioaccessibility and α-glucosidase inhibition. 
Coffee was added with milk (1:1) containing 0.1, 3.6 or 7.1% fat, 
homogenized at increasing pressure (0-150 MPa) and in vitro digested. 
Using milk with the highest fat concentration (7.1%) promoted the 
formation of smaller particles after HPH treatment, as well as upon 
digestion. Digested samples with the highest fat content also presented 
lower ζ-potential, suggesting higher stability. Chlorogenic acids (CGAs) 
bioaccessibility and α-glucosidase inhibition were evaluated upon in 
vitro digestion. CGAs bioaccessibility increased from nearly 25% to >50% 
by adding milk and using HPH. These could promote CGAs micellarization, 
reducing their susceptibility to degradation during digestion. Properly 
combined milk and HPH also improved α-glucosidase inhibitory effect. No 
correlation was found between CGAs bioaccessibility and α-glucosidase 
inhibition, suggesting that other components may govern antidiabetic 











I would like to submit the manuscript entitled “Fat concentration and high-pressure 
homogenization affect the structural organization, the chlorogenic acid bioaccessibility 
and the α-glucosidase activity of milk-based coffee beverages” by Marilisa Alongi, 
Sonia Calligaris and Monica Anese for consideration for publication in Journal of 
Functional Foods. 
This study is part of a Ph.D. research project aimed at evaluating the effect of 
technological interventions, i.e. formulation and processing, on the bioactivity of some 
foods. To this regard, a previous paper (Alongi, M., & Anese, M. 2018. Effect of coffee 
roasting on in vitro α-glucosidase activity: inhibition and mechanism of action. Food 
Research International, 111, 480–487) demonstrated that roasting affected the ability of 
coffee to inhibit α-glucosidase and thus to exert an antidiabetic effect. 
The present work further investigated on coffee ability to inhibit α-glucosidase as 
affected by formulation, i.e. milk addition, and processing, i.e. high-pressure 
homogenization. Results showed that a proper combination of these factors can 
positively affect the bioaccessibility of phenolic compound and the antidiabetic ability 
of coffee, suggesting the potential of technological interventions as a strategic tool to 












Detailed response to Reviewers 
 





In this manuscript, the authors evaluated the bioaccessibility of chlorogenic acids and the alpha-
glucosidase activity of milk-based coffee beverages prepared with the same proportion of milk but 
modifying the fat content and the conditions of high-pressure homogenization and later subjected to 
an in vitro digestion. It is an interesting study, well designed and I would like to highlight the very 
good discussion of the results performed by the authors, properly connecting their results with 
current knowledge on the topic. In my opinion, only some minor modifications should be included 
in the manuscript: 
 
Abbreviations included in the highlights, the abstracts and the keywords should be defined the first 
time they are mentioned. 
The highlights, the abstract and the keywords were modified to address reviewer comment. 
 
Page 5, lines 73-83. This should be summarized; there is no need to provide all the methodological 
aspects of the study. 
This section was reduced as suggested by the reviewer (lines 81-83). 
 
Some previous study with other beverages, such as cocoa beverage and tea, have provided 
contradictory results on the role of milk on bioaccessibility and even in vivo bioavailability. I think 
the authors should (briefly) mention how their results connect with these studies, even if these 
products do not contain the same classes of phenolic compounds. 
The discussion was implemented with further considerations (lines 318-323). 
 
Reviewer #2:  
 
Overall Comments to the authors: The authors planned all experiments with the aim to study the Fat 
concentration and high-pressure homogenization affect the structural organization, the chlorogenic 
acid bioaccessibility and the <alpha>-glucosidase activity of milk-based coffee beverages. 
However, I think this topic of manuscript is more suitable food processing technology rather than 
functional food field. The results could not truly reflect commercial coffee beverages. I recommend 
this paper for major revision. 
 
Specific comments: 
Line 10: the specific of this higher fat concentration is? 
Fat concentration was specified as requested by the reviewer (line 11). 
 
Line 45: Are all functional properties due to the chlorogenic acid? Please explain this relationship. 
The sentence was rephrased to clarify this point (lines 50-52). 
 
Line 52: The measurement of bio-accessibility should be given in this concept 
Details were added in the text as recommended by the reviewer (lines 58-61). 
 
Line 57: healthy properties should be replaced by healthy benefits. 
The suggested change was made (line 65). 
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Line 71: what is the other compounds formed upon roasting? Phenolic compounds? 
Details were added in the text (line 79). 
 
Line 86: Coffee brew was dissolved in deionized water (10 mg/mL), however, I think this 
concentration is too low. The coffee blends drinking on the market is suitable for the powder to 
water ratio of 1:10 or 1:20. The content of coffee can influence the performance of high-pressure 
homogenization. 
Coffee brew was prepared to obtain a 20 mg/mL concentration, which allowed preparing a 
beverage containing 10 mg/mL. The latter is the concentration reported by the producer (Nescafè 
Gran Aroma, Nestlè, Vevey, Swiss) and agrees with data reported in the literature for instant coffee 
beverages (Mills et al., 2013; Tagliazucchi et al., 2012). The text was modified to clarify this point 
(line 87; lines 89-91). 
With reference to high-pressure homogenization, it is worth to note that the dry matter coming from 
coffee was much lower (1-2%) than that coming from milk (around 13%), so that HPH performance 
were reasonably not affected by coffee concentration. 
 
Line 119: The source of method should be given 
The reference was added in the text (line 121). 
 
Line 187: reported should be replaced by shown 
The suggested change was made (line 186). 
 
Line 204: what is the latter? 
The latter was referred to coffee brew. The text was modified to clarify this point (line 203). 
 
Line 329: the present literature should be given 
Literature was added (line 336). 
 
Line 364: These factors also affected the ability of coffee to reduce type 2 diabetes risk by 
inhibiting <alpha>-glucosidase? Please describe in detail 
Details about fat concentration and pressure combinations can be found in lines 347-350. 






The author aimed to investigate the effect of coffee beverage formulation and homogenization 
pressure on the bioaccessibility of coffee chlorogenic acids and inhibitory effect against <alpha>-
glucosidase activity upon in vitro digestion. A two-variable face-centered central composite design 
was also used to maximize <alpha>-glucosidase inhibitory capacity of digested coffee beverage. 
The subject matter is interesting and the motivation of designing coffee beverage to improve the 
health-promoting performances of coffee is meaningful, but there are some mistakes and questions 
as detailed in the follows. 
 
Materials and methods: 
Line 148-149, 160: Please explain what the digested sample concentration is. I saw you used coffee 
concentration as x-axis in Figure 2 and Figure 4. But initial coffee concentration in coffee brew and 
coffee-milk beverage are 10 and 5 mg/mL respectively, then they were diluted 2 times at each 
digestion stage (8 times dilution in total). So what is the final coffee concentration in coffee brew 
and coffee-milk beverage group after in vitro digestion and how did you get the concentration 
gradient as you showed in Figure 2 and 4? 
Sample preparation and concentrations were clarified in the text (line 87; lines 89-91; lines 159-
160). 
 
Results and discussion: 
Line 240-242, 329-332: Considering experiment design, it is not logical to conclude that all of 
observed inhibition against <alpha>-glucosidase only results from coffee and the milk addition 
could affect coffee inhibitory effect not directly act as a <alpha>-glucosidase inhibitor after 
digestion. Please supplement in vitro digestion experiments without any food or with milk only as a 
negative control of coffee brew group and coffee beverage group respectively to understand the role 
milk played in inhibiting <alpha>-glucosidase as a part of digested sample. 
Alpha-glucosidase inhibition was already tested with controls lacking inhibitors and no inhibitory 
effect against alpha-glucosidase was found. The text was clarified, and details were added (lines 
153-154; lines 232-234; lines 326-328). 
 
 
Reviewer #4: Manuscript Number: JFF-D-19-00655 
 
Comments: 
The paper contains some interesting findings, but the manuscript will require major revisions, 
including proper formatting and rewriting to bring the paper to a suitable state for publication. 
On my opinion, this paper is suitable for publication after some improvements; however, the 
novelty of the work is poor. 
 
Line 1: In title, I would make it short. Is not clear what it means with "structural organization" of 
what? An example "Fat concentration and high-pressure homogenization effect on chlorogenic acid 
bioaccessibility and <alpha>-glucosidase activity of milk-based coffee beverages". 
The title was modified as suggested by the reviewer. 
 
Abstract: would be interesting to have a small sentence showing study novelty and reasons for this 
study. Why applying high-pressure homogenization to a beverage? It is common in industry? 
As suggested by the reviewer, the abstract was implemented by elucidating the aim of the study 





Introduction: There is a lack of information about high-pressure homogenization. I don’t understand 
why applying this technique to mixture both beverages? The way they are mixtured will have a 
detrimental effect on particle size and the type of emulsion formed. This represents reality? If is in 
the title is important for work, explain this better. 
Since its development in the early ‘80s (US patent no. 4,533,254), high pressure homogenization 
(HPH) has been widely applied in the food industry, especially for the fat globule particle size 
reduction and thus stabilization of dairy emulsions. Actually, this technology does not present a 
detrimental effect on emulsion, but on the contrary, it allows the formation of smaller and thus 
more stable micelles, which were also inferred to protect bioactive compounds from degradation 
during digestion. Details were added in the introduction section (lines 40-43). 
 
Line 73-74: "Based on this, the aim of the study was to investigate the effect of coffee brew 
formulation (not containing or containing milk at different fat concentrations)" 
 (with and without milk at different fat concentrations). 
The text was modified as suggested by the reviewer (lines 81-82). 
 
Material and Methods 
Section 2.2: Is not clear if authors prepare beverage and immediately they went to gastrointestinal 
tract. There is a time for stabilization? If so did they monitored if the emulsion is stable or if there is 
some phase's separation before digestion? What samples were submitted to digestion? Only the 
mixture of coffee and milk? This is not clear in this section. 
Both coffee brew and beverages were digested immediately after preparation and no phase 
separation was observed during this timeframe. Details were added in the text (line 101).  
 
Section 2.3, line 115: Why authors used 10kDa membrane? The pore size is not very high to retain 
enzymes? Shouldn't they use 3 kDa instead? 
To our knowledge, the bioaccessibility upon in vitro digestion has been evaluated based on different 
techniques. Some authors apply a simple centrifugation step and recover the supernatant 
(Quintero-Flórez et al., 2017), some authors apply a filtration using 0.2 μm filters (Cardinali, 
Linsalata, Lattanzio, & Ferruzzi, 2011), and some other authors apply an ultrafiltration: in this 
case, the cut-off of membranes varies in the range 3-12 kDa (Tagliazucchi, Helal, Verzelloni, & 
Conte, 2012; Dinnella, Minichino, D’Andrea, & Monteleone, 2007). It is thus reasonable that the 
10 kDa cut-off applied in the present research was able to retain enzymes and guarantee a proper 
evaluation of phenolic compound bioaccessibility and alpha-glucosidase activity. 
 
Line 143: the undigested sample was the same submitted to digestion? Or they were different 
samples? Because if they were separated samples how authors guarantee the undigested sample had 
the same concentration in the sample submitted to digestion? 
Samples were prepared in a single batch and split between undigested and digestion. Details about 
sample preparation were reported in the materials and methods section (lines 97-98). 
 
Results and Discussion 
Section 3.1.2: Authors do not verify the appearance of degradation products formed from CGAs 
degradation? The appearance of new peaks formed, like quinic acid increase? 
Line 238: what are the possible reasons for digested coffee being better inhibiting glucosidase than 
undigested? Maybe small molecules formed during phenolics degradation are interacting with the 
enzyme. This study would require a LC-MS study to make this relation. 
The authors are aware that digestion may induce the formation of other compounds besides 
chlorogenic acids (Baeza, Sarriá, Bravo, & Mateos, 2018). However, one of the aims of the present 
research was to understand how technological interventions, such as high-pressure homogenization 
and milk-based formulation, could affect chlorogenic acid bioaccessibility. As reported in the 
5 
 
introduction section, we focused on this class of compounds as they are considered the major 
responsible for coffee consumption-related health benefits and they represent the most important 
class of phenolic compounds in coffee (Iwai et al., 2012; Johnston, Clifford, & Morgan, 2003; 
Clifford & Knight, 2004). 
The authors agree with the reviewer about the possible interaction of smaller molecules formed 
upon digestion with the enzyme and that investigating more in depth the composition of digested 
coffee is necessary to elucidate the role of coffee components towards alpha-glucosidase inhibition. 
Indeed, ongoing research is focusing on the identification of degradation products formed from 
coffee phenolics upon digestion and on their role in coffee health benefits. 
 
Section 3.2: Why authors do not apply the central composite design to find the best conditions of 
processing for phenolics preservation 
As a relationship between phenolic content and alpha-glucosidase inhibition was not found, the 
authors decided to study the best conditions able to maximize the aspect more specifically related to 
coffee health benefits, i.e. the alpha glucosidase inhibitory capacity. 
Highlights 
Milk fat and high-pressure homogenization (HPH) affected beverage structure and bioactivity 
Higher fat concentration and pressure induced size decrease and ζ-potential increase 
Milk presence and HPH increased chlorogenic acid bioaccessibility from 25% to >50% 
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This study aimed at investigating the effect of coffee formulation and high-pressure homogenization 8 
(HPH) on chlorogenic acid bioaccessibility and α-glucosidase inhibition. 9 
Coffee was added with milk (1:1) containing 0.1, 3.6 or 7.1% fat, homogenized at increasing 10 
pressure (0-150 MPa) and in vitro digested. Using milk with the highest fat concentration (7.1%) 11 
promoted the formation of smaller particles after HPH treatment, as well as upon digestion. 12 
Digested samples with the highest fat content also presented lower ζ-potential, suggesting higher 13 
stability. Chlorogenic acids (CGAs) bioaccessibility and α-glucosidase inhibition were evaluated 14 
upon in vitro digestion. CGAs bioaccessibility increased from nearly 25% to >50% by adding milk 15 
and using HPH. These could promote CGAs micellarization, reducing their susceptibility to 16 
degradation during digestion. Properly combined milk and HPH also improved -glucosidase 17 
inhibitory effect. No correlation was found between CGAs bioaccessibility and -glucosidase 18 
inhibition, suggesting that other components may govern antidiabetic properties of coffee. 19 
Keywords: 20 
coffee; milk; fat concentration; high pressure homogenization; in vitro digestion; -glucosidase 21 




































































1. Introduction 23 
Recent developments in the food and nutrition disciplines have established that the functionality of 24 
bioactive compounds strongly depends not only on food composition but also on its structural 25 
organization, as well as on the interaction with co-ingested components (Salvia-Trujillo, Qian, 26 
Martín-Belloso, & McClements, 2013). Different physicochemical and biochemical mechanisms 27 
might be involved in modifying the functionality of bioactive molecules, especially during digestion 28 
(McClements & Xiao, 2014). For instance, the rate of release of bioactive components from the 29 
matrix, their inclusion in the micelles, as well as their reaction kinetics with other reactants and co-30 
ingested materials in the gastrointestinal tract can boost or decrease their bioactivity (McClements 31 
& Xiao, 2014). 32 
Coffee brews represent a suitable study case to illustrate this behavior. After being discovered in the 33 
fifteenth century in Ethiopia, within a century, coffee consumption had rapidly spread in Europe 34 
and, later, worldwide (Nehlig, 1999). There are significant differences in the consumption pattern 35 
throughout the world, including brew preparation and the addition of ingredients, such as sugar and 36 
milk. Coffee-milk based beverages can be regarded as emulsions in which the lipid phase, i.e. milk 37 
fat, is dispersed in a water phase containing both coffee constituents (mainly melanoidins, organic 38 
acids, and flavors) and milk components (mainly whey proteins and caseins). 39 
Dairy emulsions, such as milk-based beverages, are commonly stabilized by the application of high-40 
pressure homogenization (HPH) (Paquin, 1999). Besides the higher stability due to the formation of 41 
smaller micelles, these were also presumed to protect bioactive compounds from degradation during 42 
digestion (Otemuyiwa, Williams, & Adewusi, 2017). 43 
It is worthy to note that the consumption of ready-to-drink milk beverages supplemented with 44 
coffee has increased markedly. Consumers mainly drink coffee as a stimulant, due to its caffeine 45 
content, which can increase alertness, energy, and ability to concentrate. Nonetheless, in the 46 




































































& Crozier, 2014), including the protection against cardiovascular diseases, as well as 48 
antihypertensive, anti-inflammatory, immunoprotective, anti-cancer (Palmioli et al., 2017), anti-49 
aging (Amigoni et al., 2017), neuroprotective (Ciaramelli, Palmioli, & Airoldi, 2019) and 50 
antidiabetic (Iwai et al., 2012; Johnston, Clifford, & Morgan, 2003) effects. These have been 51 
attributed to chlorogenic acids (quinic esters of hydroxycinnamic acids, CGAs), which are the most 52 
important class of coffee polyphenols (12–18% dry weight in green coffee) and can be clustered 53 
into three main groups: caffeoylquinic acids (CQAs), with 5-O-caffeoylquinic acid (5-CQA) being 54 
the most abundant, feruloylquinic acids (FQAs), and di-caffeoylquinic acids (di-CQAs) (Clifford & 55 
Knight, 2004). It is noteworthy that CGAs bioactivity is definitively affected by the digestion 56 
process (Baeza, Sarriá, Bravo, & Mateos, 2018) and may be related to their bioaccessibility, i.e. 57 
their ability to reach the small intestine upon digestion, as defined by Ferruzzi (2010). The 58 
bioaccessibility is commonly assessed trough in vitro simulation of the digestion process and is 59 
computed as the ratio between the concentration of the compounds found after the intestinal 60 
digestion phase and those originally present in undigested food (Ferruzzi, 2010). Coffee digestion 61 
was actually simulated in few studies dealing with phenolic compound bioaccessibility and revealed 62 
that less than 30% of coffee phenolic compounds was bioaccessible (Podio et al., 2015; López-63 
Froilán, Ramírez-Moreno, Podio, Pérez-Rodríguez, Cámara, Baroni, Wunderlinc, et al., 2016). 64 
Beside these health benefits, chlorogenic acids resulted also able to inhibit α-glucosidase, a 65 
hydrolase located on the intestinal cell membrane of the ciliated epithelium, responsible for the 66 
release of glucose from oligo- and disaccharides (Chiba, 1997) and thus targeted by several 67 
antidiabetic drugs (Akkarachiyasit, Charoenlertkul, Yibchok-Anun, & Adisakwattana, 2010). 68 
However, most studies refer to model systems, such as phenolic compounds purified from coffee 69 
(Murase et al., 2012; Iwai et al., 2012; Johnston et al., 2003), whereas only a few papers deal with 70 
the whole beverage, which includes also other molecules (Moreira, Nunes, Domingues, & Coimbra, 71 
2012). Additionally, most of these studies refer to undigested matrices; whereas to our knowledge 72 




































































understand which was the effect of the whole food (i.e. coffee brew) and of processing (i.e. 74 
roasting) against type 2 diabetes, in a previous work we investigated the ability of brews obtained 75 
from differently roasted coffees towards α-glucosidase inhibition (Alongi & Anese, 2018). Results 76 
highlighted that the brew capability in inhibiting the enzyme increased with the increase in the 77 
roasting degree. Surprisingly, no correlation was found between the ability to inhibit α-glucosidase 78 
and the chlorogenic acid content, suggesting that other compounds formed upon roasting, such as 79 
melanoidins, may play a role in determining the antidiabetic effect of coffee (Iwai et al., 2012; 80 
Johnston et al., 2003). 81 
Based on this, the aim of the study was to investigate the effect of coffee brew formulation (with 82 
and without milk at different fat concentrations) and HPH on CGAs bioaccessibility and inhibitory 83 
effect against α-glucosidase activity upon in vitro digestion. 84 
2. Materials and methods 85 
2.1. Sample preparation and high-pressure homogenization 86 
Coffee brew was prepared by dissolving instant coffee (Nescafè Gran Aroma, Nestlè, Vevey, 87 
Swiss) in deionized water (20 mg/mL). Skimmed milk (0.1% fat, w/w) and cream (35% fat, w/w) 88 
(Granarolo S.p.A, Bologna, Italy) were purchased on the local market and properly mixed to obtain 89 
milk containing 3.6% and 7.1% (w/w) fat, respectively. Coffee brew (50%, w/w) and milk 90 
containing 0.1, 3.6 and 7.1% fat (50%, w/w) were mixed to obtain 10 mg/mL coffee beverages with 91 
low, intermediate and high-fat content, respectively. These beverages were homogenized by using a 92 
continuous lab-scale high-pressure homogenizer (Panda Plus 2000, GEA Niro Soavi, Parma, Italy) 93 
supplied with two PS type homogenization valves with a flow rate of 10 L/h was used to treat 150 94 
mL of sample. The first valve was the actual homogenization stage and was set at 50, 100 and 150 95 
MPa. The second valve was set at a constant value of 10 MPa. At the exit of the homogenizer, the 96 




































































samples to T < 20 °C. Coffee brew and beverages were aliquoted to obtain samples from a same 98 
batch to be directly analyzed or to be in vitro digested before analyses. 99 
2.2. In vitro digestion 100 
In vitro digestion was carried out on coffee brew and coffee beverages according to the protocol 101 
proposed by Minekus et al. (2014), immediately after preparation. Briefly, the simulated salivary 102 
(SSF), gastric (SGF) and intestinal (SIF) fluids were prepared and stored at 4 °C. The fluids were 103 
preheated to 37 °C just before in vitro digestion. The oral phase was started by adding to the sample 104 
an α-amylase solution prepared in SSF and providing 75 U/mL activity in the final mixture, 105 
CaCl2(H2O)2 (0.3 M) to achieve 0.75 mM in the final mixture and SSF. The final ratio of food to 106 
SSF was 50:50 (v/v). The sample was maintained at 37 °C under stirring for 2 min. The gastric 107 
phase was then started by mixing 5 parts of bolus with 4 parts of SGF, a pepsin solution prepared in 108 
SGF and providing 2,000 U/mL activity in the final mixture and CaCl2 to achieve 0.075 mM in the 109 
final mixture. The pH was adjusted to 3.0 with HCl (1 M) and water was added to achieve a final 110 
ratio of bolus to SGF of 50:50 (v/v). The mix was stirred at 37 °C for up to 2 h. Five parts of chyme 111 
were mixed with 4 parts of SIF, a pancreatin solution prepared in SIF and providing 100 U/mL 112 
activity in the final mixture, bile salts prepared in SIF and providing 10 mM concentration in the 113 
final mixture and CaCl2 to 0.3 mM in the final mixture. The pH was adjusted to 7.0 with NaOH (1 114 
M) and water was added to achieve a final ratio of chyme to SIF of 50:50 (v/v). The mix was stirred 115 
at 37 °C for up to 2 h. At the end of the intestinal phase, samples were subjected to ultrafiltration 116 
with 10 kDa cut-off (Vivaspin 500, Sartorius, Varedo, Italy) at 13000 g for 25 min at 4 °C (Hittich 117 
MIKRO 20 Centrifuge, Tuttlingen, Germany). The ultrafiltered sample was considered as the 118 
bioaccessible fraction (Tagliazucchi, Helal, Verzelloni, & Conte 2012). 119 
2.3. Particle physicochemical characterization 120 
The particle size distribution of digested samples was measured by dynamic laser light scattering 121 




































































Samples were diluted 1:1000 (v/v) with deionized water and placed in a cell where the laser light, 123 
set at 173 ° angle, was scattered by the particles. Particle size was reported as volume-weighted 124 
mean diameter in nm. The ζ-potential was also measured by placing the diluted samples in a 125 
capillary cell equipped with two electrodes to assess particle electrophoretic mobility. 126 
2.4. Chlorogenic acid quantification and bioaccessibility 127 
Chromatographic quantification of chlorogenic acids was performed on undigested and digested 128 
samples following the method proposed by Mills, Oruna-Concha, Mottram, Gibson, & Spencer 129 
(2013). An HPLC pump (LC-10AT VP, Shimadzu Corporation, Kyoto, Japan) equipped with a 130 
diode array detector (SPD-10 AT VP, Shimadzu Corporation, Kyoto, Japan) and with an inverse 131 
phase apolar C18 column (5 µm, 250 x 4.6 mm, Alltima, Lokeren, Belgium) was used. The 132 
injection valve (Rheodyne, Sigma-Aldrich, Milano, Italy) was equipped with a 20 μL plastic loop 133 
and samples were injected using a syringe (SGE LC, 100 µL, FN). The elution was carried at a flow 134 
rate of 1 mL/min in gradient mode using 5% methanol (Sigma-Aldrich, Milano, Italy) and 95% 135 
water containing 0.1% HCl 5 N (solvent A), and 50% acetonitrile (Sigma-Aldrich, Milano, Italy) 136 
and 50% water containing 0.1% HCl 5 N (50%) (solvent B) as mobile phase. Gradient was set as 137 
follows: solvent A was held at 95% for the first 5 min, decreased to 50% and held at this level up to 138 
40 min; then decreased further to 0% and held up to 59.9 min; finally, 95% solvent A was reached 139 
and held up to 60 min. The detection was conducted at 320 nm. Quantification was carried out 140 
using external standards. Calibration curves were linear (R
2
 > 0.995) in the 2.0 to 200.0 mg/L 141 
concentration interval. Peak integration was performed by using Polyview 2000 software (Ver. 5.3, 142 
Varian, Texas, USA). 143 
Bioaccessibility was determined as the ratio between the concentration of the compound in the 144 




































































2.5. α-Glucosidase inhibition 146 
The inhibitory activity of digested coffee brew and beverages against α-glucosidase was assessed 147 
spectrophotometrically (UV-2501PC, UV-VIS Recording Spectrophotometer, Shimadzu 148 
Corporation, Kyoto, Japan), as previously described (Alongi & Anese, 2018). Different aliquots of 149 
sample were introduced in 1 mL capacity cuvettes in the presence of 30 μL α-glucosidase solution 150 
(0.04 mg/mL in 0.1 M phosphate buffer, pH=7, corresponding to 1 U/mL), and phosphate buffer 151 
(100 mM, pH 7) to the volume of 900 μL, and mixed well. After incubation at 37 °C for 10 min, the 152 
reaction was started by adding 100 µL of 5 mM 4-nitrophenyl-α-D-glucopyranoside (Sigma-153 
Aldrich, Milano, Italy) solution in 100 mM phosphate buffer (pH 7.0) as substrate. Absorbance was 154 
recorded at 405 nm during 10 min after every 30 s. Controls lacking inhibitors (i.e. digestive 155 
mixture without sample and digested milk) were run and defined the control activity in each 156 
experiment. The α-glucosidase inhibition carried out by digested samples was calculated using 157 
Equation 1: 158 
                             
  
  
         Equation 1 159 
where ks and kc were the kinetic constants in the presence and in the absence of the inhibitor (i.e. 160 
digested coffee brew and beverages), respectively. The inhibitory activity (%) against -glucosidase 161 
was plotted vs the concentration of digested sample (0 to 2.5 mg/mL for coffee brew and 0 to 1.25 162 
mg/mL for coffee beverages), and a logarithmic model was used to fit data so that the half-maximal 163 
inhibitory concentrations (IC50), i.e. the concentration of sample required to produce a 50% 164 
inhibition against α-glucosidase, was calculated. 165 
2.6. Polynomial equations and statistical analysis 166 
Modeling was aimed at identifying the combination of fat concentration and pressure able to 167 
optimize the inhibitory activity against α-glucosidase, by minimizing the IC50. In particular, a 2-168 




































































concentration and pressure and were set at 0.1, 3.6 and 7.1% (w/w) and at 50, 100 and 150 MPa, 170 
respectively. The CCF was completed by a central point (combination of the intermediate values of 171 
the two factors). All the factorial points were replicated once, while the central point was replicated 172 
3 times (Table S1). A second order response surface was fitted to the observed data according to 173 
Equation 2. 174 
          
 
          
  
            
 
           Equation 2 175 
where B0 is a constant, Bi, Bii, and Bij are regression coefficients of the model, xi and xj are the 176 
independent variables in coded values, and k is the number of factors. 177 
Shapiro-Wilk test was used to evaluate normality of the data, while the possible presence of outliers 178 
and the homogeneity of variance were evaluated by residual analysis. The goodness of fit was 179 
measured with the adjusted determination coefficient (R
2
adj). p-Values for the coefficients of the 180 
response surface were defined using standard t-test. Contour plot was drawn to illustrate the effect 181 
of the considered factors on the IC50. 182 
Results are averages of three measurements and are reported as mean value ± standard deviation. 183 
Analysis of variance (ANOVA) was performed by using R (version 3.2.3, The R Foundation for 184 
Statistical Computing, Vienna, Austria). Bartlett's test was used to check the homogeneity of 185 
variance and Tukey test was used to test for differences between means (p < 0.05). 186 
3. Results and discussion 187 
3.1. Effect of in vitro digestion on coffee brew 188 
3.1.1. Chemical and physical properties 189 
As shown in Fig. 1, coffee brew presented a multimodal particle size distribution, revealing the 190 
presence of two families of compounds, with an average diameter corresponding to 255 ± 10 and 191 
5560 ± 16 nm, respectively. The smaller family could be represented by phenolic compound-protein 192 
aggregates, while larger particles could have formed during coffee powder production, upon water 193 




































































Bourvellec & Renard, 2012; Gmoser et al., 2017). Upon in vitro digestion, a single family of 195 
compounds (298 ± 5 nm) was observed. The latter might be formed as a result of the digestive 196 
enzyme activity, leading to the degradation of native coffee brew particles and the formation of new 197 
ones. In particular, the presence of bile salts, together with amphiphilic molecules deriving from 198 
coffee (i.e. fatty acids and phospholipids), could lead to the formation of mixed micelles, containing 199 
several digestion products (Salvia-Trujillo et al., 2017). 200 
A significant change (p < 0.05) in the ζ-potential was also observed upon in vitro digestion. In 201 
particular, non-digested coffee presented a value of -17.45 ± 1.34 mV, while the ζ-potential of 202 
digested sample was -32.45 ± 1.63 mV. Such a difference can be attributed to the presence of bile 203 
salts and other digestion products on mixed micelle surface, leading to higher stability of the 204 
digested system, due to particle repulsion (Salvia-Trujillo et al., 2013). 205 
3.1.2. Chlorogenic acids and bioaccessibility 206 
As in vitro digestion induced changes in the structural properties of coffee brew, this was also 207 
analyzed for chlorogenic acid (CGAs) content, since these compounds represent the most abundant 208 
class of polyphenols in coffee (Clifford, 1985; Mills et al., 2013). 209 
As shown in Table 1, two major families of CGAs, namely caffeoylquinic acids, i.e. 3-210 
caffeoylquinic (3-CQA), 4-caffeoylquinic (4-CQA) and 5-caffeoylquinic (5-CQA), and feruylquinic 211 
acids, i.e. 5-feruylquinic (5-FQA) and 4-feruylquinic (4-FQA), were identified and quantified. As 212 
expected, 5-CQA was the most abundant compound, and, together with 3-CQA, accounted for more 213 
than 70% of the overall CGAs, in agreement with previous data showing that these compounds 214 
represent more than half of coffee CGAs (Alongi & Anese, 2018). A significant reduction, up to 215 
80%, in CGAs concentration was observed upon in vitro digestion (Table 1). These results agree 216 
with data reported by other authors for coffee (Olthof, Hollman, & Katan, 2001; Podio et al., 2015; 217 
López-Froilán et al., 2016), as well as for other foods such as tea (Record & Lane, 2001) and fruit 218 




































































be due not only to the activity of digestive enzymes but also to the low stability of phenolic 220 
compounds to pH modification during the digestion process. In addition, phenolic compounds can 221 
undergo several reactions during in vitro digestion, such as polymerization, epimerization, and auto-222 
oxidation, as well as complexation with metal ions present in the digestive mixture (Rodríguez-223 
Roque, Rojas-Graü, Elez-Martínez, & Martín-Belloso, 2014). Nonetheless, the phenolic profile of 224 
digested coffee resulted analogous to that of the undigested sample, with 5- and 3-CQA still 225 
representing the 70% of overall CGAs (Table 1). To better understand which was the ratio of 226 
phenolic compounds surviving the digestion process and thus available for uptake by the intestinal 227 
mucosa (Ferruzzi, 2010), their bioaccessibility was computed (Table 1). The latter accounted for 228 
less than 25% and no significant differences were observed among single CGAs, that presented a 229 
bioaccessibility always lower than 30%, suggesting that all CGAs seemed equally susceptible to 230 
degradation upon in vitro digestion. 231 
3.1.3. α-Glucosidase inhibition 232 
Previous research demonstrated that undigested coffee is able to inhibit α-glucosidase (Alongi & 233 
Anese, 2018). However, this enzyme is located at intestinal level (Chiba, 1997) and thus it can 234 
come in contact only with digested food. As changes in the physical and chemical properties (Fig. 235 
1) as well as in CGAs content (Table 1) were observed upon in vitro digestion, the digested coffee 236 
brew was tested for its ability to inhibit α-glucosidase (Fig. 2). A control represented by the 237 
digestive mixture not containing coffee brew was also tested and did not present any inhibitory 238 
effect in the whole range of analyzed concentrations (data not shown). On the contrary, the 239 
inhibition carried out by digested coffee brew against -glucosidase increased in a concentration-240 
dependent manner (Fig. 2) with an IC50 of 0.94 mgdw/mL. The latter was up to 3-fold lower than 241 
that reported in the literature for undigested coffee beverages (Alongi & Anese, 2018). In other 242 
words, digested coffee would be more efficacious than undigested one in inhibiting -glucosidase, 243 




































































(Table 1). To this regard, it is noteworthy that the same authors observed an inverse correlation 245 
between chlorogenic acid content and -glucosidase inhibition and suggested that other 246 
compounds, such as Maillard reaction products, besides phenolic ones may play a role in inhibiting 247 
the enzyme. 248 
3.2. Effect of the addition of milk on coffee properties upon in vitro digestion 249 
As coffee is often consumed with the addition of milk and this was demonstrated to affect the 250 
bioaccessibility of phenolic compounds (Tagliazucchi et al., 2012), in the second part of this 251 
research the effect of milk addition, and relevant fat content, and particle size distribution on coffee 252 
inhibitory capacity against -glucosidase was evaluated. In particular, coffee was added with milk 253 
(1:1 w/w) having a different fat concentration (0.1, 3.6 and 7.1%), homogenized with high pressures 254 
(50, 100 and 150 MPa) and in vitro digested. Table 2 shows the particle size distribution of coffee 255 
beverages before and after in vitro digestion. Increasing fat concentration to 7.1% produced an 256 
overall reduction in the average particle diameter of coffee beverages before in vitro digestion. HPH 257 
also affected the particle size distribution. When considering the lowest fat concentration (<0.1%), 258 
peaks can be mainly related to milk protein aggregates that, upon HPH treatment, were disrupted as 259 
evidenced by the change from monomodal to multimodal particle distribution. On the contrary, in 260 
beverages containing milk at 3.6 and 7.1% fat, the observed signals can be regarded to both fat 261 
globules and proteins aggregates. After HPH treatments the monomodal distribution was 262 
maintained with a significant shift to lower particle sizes. In particular, by increasing the pressure, a 263 
reduction in average particle diameter from 955 to 396 nm was noted for the 3.6% fat containing 264 
beverage and from 190 nm to 106 nm in the case of that with 7.1% fat. As expected, the mechanical 265 
forces suffered by the product during HPH process induced the disruption of dispersed particles, 266 
giving a reason for emulsions with a different structural organization. 267 
After in vitro digestion, three particle families were identified: the first ranging from 30 to 70 nm, 268 




































































295 nm were also observed in digested coffee brew (Fig. 1) and were attributed to the presence of 270 
mixed micelles. The occurrence of smaller and larger particles upon digestion of coffee beverages 271 
could instead be attributed to the presence of milk. Several authors (Garcia, Antona, Robert, Lopez, 272 
& Armand, 2014; Mercan, Sert, & Akin, 2018; Hayes & Kelly, 2003) observed two major particle 273 
families, with average diameter in the order of magnitude of 100 and 10,000 nm, respectively, upon 274 
homogenization and in vitro digestion of milk. The first family could be represented by fat globules, 275 
while the second might include both aggregates of fatty acids, bile salts and undigested fat particles 276 
(Singh, Ye, & Horne, 2009; Salvia-Trujillo et al., 2013), as well as digested milk proteins (Koutina, 277 
Ioannidi, Melo Nogueira, & Ipsen, 2017). Interestingly, the higher was the fat content, the higher 278 
was the volume of smaller particles also after in vitro digestion (Table 2). These results suggest that 279 
the presence of higher fat concentrations could not only promote the formation of smaller particles 280 
upon HPH treatment but also induce the development of smaller micelles during digestion. To this 281 
regard, Salvia-Trujillo et al. (2013) observed that increasing the lipid surface area exposed to 282 
pancreatic lipase led to a decrease in droplet size obtained upon digestion and to a higher extent of 283 
lipid digestion. 284 
To understand if the differences observed in particle size distribution also affected the stability of 285 
undigested and digested coffee beverages, the latter were further analyzed for their ζ-potential (Fig. 286 
3). Overall, HPH did not affect the ζ-potential of undigested coffee beverages, while it decreased as 287 
fat concentration increased from 0.1 to 3.6% (Fig. 3). A further increase to 7.1% of fat did not 288 
modify the ζ-potential. In vitro digestion only produced minor changes in the ζ-potential when 289 
lower fat concentrations were considered. On the contrary, an outstanding difference was observed 290 
in the ζ-potential upon in vitro digestion of the coffee beverage containing the highest fat 291 
concentration, with a decrease ranging from 2- to 3-fold (Fig. 3c). It is noteworthy that samples 292 
presenting the lowest ζ-potential (Fig. 3c), and thus potentially high stability, also presented the 293 
smallest particle size distribution upon in vitro digestion (Table 2), suggesting that high fat 294 




































































(2017) reported that the presence of fat could aid the stabilization of the system during digestion by 296 
favoring mixed micelles stabilization and solubilization. These authors also reported that the 297 
addition of milk, and thus the presence of fat, plays a crucial role in enhancing phenolic availability 298 
of tea and cocoa infusions, by helping their micellarization. On the contrary, other authors reported 299 
that the presence of milk may impair phenolic compounds bioaccessibility mainly due to the 300 
binding with milk proteins (Dupas, Baglieri, Ordonaud, Tomè, & Maillard, 2006; Duarte & Farah, 301 
2011). To get an insight into the effect of the presence of milk with different fat concentration as 302 
well as of HPH treatment on chlorogenic acids, the latter were quantified in coffee beverages before 303 
and after in vitro digestion and their bioaccessibility was computed (Table 3). As shown in Table 3, 304 
the bioaccessibility of chlorogenic acids in coffee beverages was strongly affected by the presence 305 
of milk. In all cases, the addition of milk increased dramatically the bioaccessibility of CGAs 306 
moving from about 20-25% (Table 1) to values higher than 50%, up to more than 100%. These 307 
results highlighted the reduced susceptibility of CGAs to degradation upon in vitro digestion, as 308 
compared to coffee without milk, in which up to 80% of CGAs was lost after digestion (Table 1). 309 
To this regard, Duarte & Farah (2011) reported that the effect of milk on CGAs content upon 310 
digestion would depend on the milk to coffee ratio, and thus on the fat to coffee ratio, which can 311 
result in a positive or negative effect on CGAs bioaccessibility. In our experimental condition, the 312 
1:1 ratio between milk and coffee may considerably improve the health-promoting performances of 313 
coffee. Moreover, the bioaccessibility was shown to be affected both by fat content and HPH 314 
intensity. Overall, an increase in phenolic bioaccessibility was observed when coffee beverages 315 
contained milk with 0.1% fat and were treated at 50 MPa, as well as when 3.6% fat was considered 316 
and the beverage was treated at 100 MPa. This pressure, however, when combined with the lowest 317 
(i.e. 0.1%) and the highest fat level (i.e. 7.1%) led to a significant decrease in chlorogenic acid 318 
content, which accounted for nearly 50% of total CGAs. Different factors could concomitantly 319 
affect the CGAs bioaccessibility. As already pointed out, the presence of fat could reduce the 320 




































































In addition, phenolic compounds may complex with milk proteins and thus result less prone to 322 
breakdown during digestion (Dupas et al., 2006; Lamothe, Azimy, Bazinet, Couillard, & Britten, 323 
2014). Finally, the system particle size could modulate the digestion kinetics and thus CGAs 324 
bioaccessibility (Salvia-Trujillo et al., 2013). 325 
Altough contradictory effects were reported in the literature regarding the simultaneous 326 
consumption of milk with phenolic compounds on their bioaccessibility (Duarte & Farah, 2011; 327 
Tagliazucchi et al., 2012), this controversy was explained by Del Rio, Borges, & Crozier (2010) 328 
considering the different concentration of phenolic compounds. According to these authors, milk 329 
could interfere with the absorption in the case of low phenolic concentration, but it could have an 330 
opposite effect if the phenolic concentration is high enough, as in the case of coffee brew (Del Rio 331 
et al., 2010). 332 
Since the addition of milk to coffee brew induced changes in the physical and chemical properties 333 
upon in vitro digestion, digested coffee beverages, as well as digested milk samples, were further 334 
analyzed for the inhibition against -glucosidase (Fig. 4). Digested milk did not inhibit the enzyme 335 
in the whole range of analyzed concentrations (data not shown), while digested coffee beverages 336 
inhibited -glucosidase in a concentration-dependent manner (Fig. 4). The highest efficacy was 337 
observed for the beverage containing milk with 7.1% fat and treated at 100 MPa. Overall, the use of 338 
higher pressures (i.e. 100 and 150 MPa) improved the -glucosidase inhibitory capacity of all 339 
beverages. The fat content also affected the ability to inhibit the enzyme. It can be noticed that 340 
when 3.6% fat was used, all coffee beverages showed a lower inhibitory capacity against -341 
glucosidase as compared to coffee brew (Fig. 2). On the contrary, lower (0.1%) or higher (7.1%) fat 342 
levels improved the ability of coffee beverages to inhibit the enzyme. To our knowledge, despite 343 
some information is present in the literature regarding the effect of milk addition on the 344 
bioaccessibility of coffee phenolic compounds (Tagliazucchi et al., 2012), for the first time, these 345 




































































3.3. Identification of the best fat-pressure combination able to minimize IC50 347 
To define the best performing process conditions to obtain a coffee beverage with improved -348 
glucosidase inhibitory capacity, a 2-factors face-centered central composite design (CCF) was used. 349 
To this aim, fat concentration and pressure were considered as independent variables and their 350 
effect on IC50 was studied (Table S1). The regression coefficients and the relative analysis of 351 
variance of the polynomial models for the dependent variable, namely IC50, were computed (Table 352 
S2). Finally, to evaluate the effect of the independent variables on the dependent one and to predict 353 
the optimum values of each variable for minimum IC50 to be achieved, a contour-plot was generated 354 
(Fig. 5). As reported in Fig. 5, the IC50 could be minimized by different combinations of fat 355 
concentration and pressure. In particular, when a low lipid concentration was used (<0.5%), higher 356 
pressures (>125 MPa) would be required to minimize the IC50. On the other hand, when a higher 357 
lipid concentration was used (around 7%), the IC50 could be minimized by applying intermediate 358 
pressures (between 80 and 110 MPa). When these conditions were applied, an IC50 lower than 0.5 359 
mgdw/mL was obtained. This means that a proper combination of fat concentration and pressure 360 
could almost double the ability of coffee to inhibit α-glucosidase since the IC50 of coffee brew 361 
without milk was 0.94 mgdw/mL. 362 
However, it is noteworthy that the combinations able to minimize the IC50 led to a significant 363 
decrease in CGAs bioaccessibility (Table 3). It can be thus inferred that the inhibitory effect against 364 
α-glucosidase might not rely on CGAs content, despite these were reported to present antidiabetic 365 
effects through α-glucosidase inhibition (Ishikawa et al., 2007). As already reported in previous 366 
work relevant to undigested coffee (Alongi & Anese, 2018), an inverse relationship was found 367 
between the phenolic content and the efficacy in inhibiting α-glucosidase. The latter could be 368 
carried out by other compounds formed upon processing, among which are melanoidins that can 369 
incorporate phenolic compounds (Perrone, Farah, & Donangelo, 2012). Moreover, it can be inferred 370 




































































phenolic compounds and milk proteins upon high-pressure homogenization (Paquin, 1999) and 372 
digestion (Hasni et al., 2011; Ali et al., 2012) might result in a reduced bioactivity (Lorenz et al. 373 
2007, Serafini et al., 2009). 374 
4. Conclusions 375 
The results acquired in the present study pointed out that both formulation (i.e. the addition of milk 376 
with different fat content) and processing (i.e. homogenization pressure) play a key role in 377 
determining the bioaccessibility of coffee CGAs. A proper combination of milk and pressure also 378 
increased the potential of coffee to reduce type 2 diabetes risk by improving its ability to inhibit -379 
glucosidase, through IC50 minimization. However, this bioactivity was not related to CGAs 380 
bioaccessibility, and could thus rely on the presence of other compounds, as well as on more 381 
complex interactions occurring upon processing and digestion. 382 
It can be suggested that designing foods aimed at delivering defined functionalities should not only 383 
focus on increasing the bioaccessibility of single bioactive compounds but should aim at 384 
maximizing the desired bioactivity. To this purpose, the food matrix effect, including the presence 385 
of other constituents and their interactions, as well their fate upon digestion must be considered, to 386 
properly modulate technological interventions. 387 
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Captions for figures 517 
Fig. 1. Particle size distribution of coffee brew, before and after in vitro digestion. 518 
Fig. 2. -Glucosidase inhibitory activity of digested coffee brew as a function of coffee 519 
concentration. Data fitting: line, estimates; symbols, experimental data. 520 
Fig. 3. ζ-Potential of coffee beverages containing 0.1% (a), 3.6% (b) and 7.1% (c) of fat and 521 
homogenized with different pressure before and after in vitro digestion. Lowercase letters (a-b) 522 
indicate significant differences before and after in vitro digestion, uppercase letters (A-C) indicate 523 
significant differences among different pressures within the same sample. 524 
Fig. 4. -Glucosidase inhibitory activity of digested coffee beverages containing 0.1% (a), 3.6% (b) 525 
and 7.1% (c) of fat and homogenized with different pressure as a function of coffee concentration. 526 
Fig. 5. Fitted contour plot of IC50 as a function of fat concentration in coffee beverages and 527 
homogenization pressure. 528 
Table 1 
Concentration before (Undigested) and after (Digested) in vitro digestion of coffee brew, and 
bioaccessibility of 3-caffeoylquinic (3-CQA), 4-caffeoylquinic (4-CQA), 5-caffeoylquinic (5-
CQA), 5-feruylquinic (5-FQA), 4-feruylquinic (4-FQA) and total chlorogenic (Total CGAs) acids.  
CGA Undigested (mg/gdw) Digested (mg/gdw) Bioaccessibility (%) 
3 CQA 4.24 ± 0.12 
a
 1.22 ± 0.33 
b
 28.85 ± 7.78 
A
 
4 CQA 1.57 ± 0.06 
a
 0.39 ± 0.08 
b
 25.09 ± 5.27 
A
 
5 CQA 9.99 ± 0.10 
a
 2.14 ± 0.19 
b
 21.40 ± 1.86 
A
 
5 FQA 1.41 ± 0.04 
a
 0.39 ± 0.08 
b
 27.72 ± 6.01 
A
 
4 FQA 2.74 ± 0.02 
a
 0.54 ± 0.16 
b
 19.53 ± 5.95 
A
 
Total CGAs 19.95 ± 0.30 
a
 4.68 ± 0.77 
b
 23.46 ± 3.87 
A
 
Lowercase letters (a-b) indicate significant differences of concentration (p > 0.05) between undigested 





Particle size distribution of coffee beverages containing 0.1%, 3.6%, and 7.1% fat, before and after 
in vitro digestion. 
Fat content 
(%) 































































































Particle diameter (nm) 
Table 2
Table 3 
Bioaccessibility (%) of 3-caffeoylquinic (3-CQA), 4-caffeoylquinic (4-CQA), 5-caffeoylquinic (5-CQA), 5-feruylquinic (5-FQA) and 4-feruylquinic 
(4-FQA) acids, and total chlorogenic acids (Total CGAs) in coffee beverages with different fat concentration and homogenized with different 
pressure. 
 
0.1% fat 3.6% fat 7.1% fat 

























































































































































Different letters (a-d) indicate significant differences. 
Table 3
Table S1 
Combination of fat concentration and pressure of different runs and experimental results (half 
maximal inhibitory concentration, IC50) of a two-factors face-centered central composite design. 






1 0.1 50 2.76 ± 0.56 
2 0.1 150 0.70 ± 0.03 
3 7.1 50 0.92 ± 0.06 
4 7.1 150 1.23 ± 0.13 
5 0.1 100 0.92 ± 0.11 
6 7.1 100 0.50 ± 0.02 
7 3.6 50 2.05 ± 0.55 
8 3.6 150 1.22 ± 0.14 
9 3.6 100 1.18 ± 0.18 
10 3.6 100 1.12 ± 0.13 




















































































Coffee concentration (mgdw/mL) 
Figure 2



















































a, AB a, A a, AB 























































































Coffee concentration (mgdw/mL) 
c 
Figure 4
Click here to download Figure: Figure 4.docx
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